CERo Therapeutics Holdings, Inc. Common Stock (CERO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.01 (-9.60%), Market cap $0.00B, 52-week low–high $0.02 ~ $19.83.
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Financial statements, price targets, institutional (13F) holdings and related news for CERo Therapeutics Holdings, Inc. Common Stock are updated in real time on BlackAll Trade.
CERo Therapeutics Holdings, Inc. Common Stock trades at $0.01 (-9.60%). Real-time quotes and charts are available on BlackAll Trade.
CERo Therapeutics Holdings, Inc. Common Stock has a market cap of about $0.00B.
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-12